Clinical Correlation: Muscular Dystrophy

Muscular Dystrophy Overview

• Definition: Muscular dystrophies are a group of different muscle diseases where the muscles get progressively weaker and break down over time. Often, these diseases also cause problems with the heart muscle (cardiomyopathy).

• Types: There are more than 20 different kinds known today. Each type involves different genes (the instructions in our DNA) and shows different physical traits or symptoms (phenotypes), affecting either muscles closer to the body's center (proximal) or those further away (distal).

Types of Muscular Dystrophies

• Duchenne and Becker's Muscular Dystrophy

  • These types affect muscles closer to the body's center (proximal) first, before affecting muscles further away (distal)—for example, the quadriceps (thigh muscles) before the calf muscles.

  • Duchenne muscular dystrophy (DMD) is a very serious disease that is passed down through genes on the X chromosome, mainly affecting boys. It's caused by mistakes (mutations) in the dystrophin gene, which means the body either doesn't make the dystrophin protein at all.

  • Becker muscular dystrophy (BMD) is similar but usually less severe. It happens when the body makes a shorter or partially working version of the dystrophin protein.

• Facioscapulohumeral Muscular Dystrophy (FSHD): This type mostly affects muscles in the shoulders, face, and sometimes the calf muscles.

• Oculopharyngeal Muscular Dystrophy: This targets muscles around the eyes and in the throat (pharynx), making it hard to swallow or move the eyes.

• Limb Girdle Muscular Dystrophy: This affects the muscles around the shoulders, upper arms, and legs (the limb girdles).

DMD Pathophysiology

• Dystrophin Function:

  • Dystrophin is like a strong rope that connects the inside of a muscle cell to the extracellular matrix, which is the scaffolding and support structure outside the cell. This connection helps keep the muscle cell wall (membrane) strong and intact.

  • The dystrophin gene is very large, spanning over $2.5$ megabases (meaning it has a lot of genetic information), and is located on the X chromosome. It's made up of more than $79$ smaller segments called exons.

• Consequences of Dystrophin Absence: When dystrophin is missing or faulty, it leads to weak muscle cell walls (membrane fragility). This causes too much calcium to flow into the muscle cells, which damages them, leading to muscle fibers dying (myofibril death).
  Over time, the damaged muscle tissue is replaced by fat and scar-like connective tissue, making the muscle weaker.

Clinical Manifestations of DMD

• Epidemiology: DMD affects about $1$ in every $3,500$ boys and is passed down through genes linked to the X chromosome.

• Onset: Symptoms typically begin when a child is between $2$ and $4$ years old.

• Symptoms:

  • Muscle weakness starts in the muscles closer to the body's center (proximal) and then spreads to those further away (distal).

  • Gowers maneuver: This is a specific way a child with DMD gets up from the floor. They use their hands to push on their knees or thighs to help them stand because their hip and leg muscles are too weak.

  • Calf hypertrophy: The calf muscles often look unusually large, but this is usually because muscle tissue has been replaced by fat and connective tissue, not because the muscles are strong.

  • Elevated serum muscle enzymes: Blood tests show very high levels of muscle enzymes, especially creatine kinase (which can be $40$ to $100$ times higher than normal), indicating that muscle cells are being damaged.

• Progression:

  • By around age $13$, many boys with DMD need to use a wheelchair.

  • The disease shortens a person's lifespan, mainly because of serious heart problems (cardiac failure) and breathing difficulties (respiratory failure).

Distinctive Features and Signs in DMD

• Gower's Sign: This term describes the difficulty a child has getting up from the floor, where they use their arms to 'walk' their hands up their legs for support because their knee and hip muscles are weak.

• Muscle Involvement:

  • Muscle weakness occurs on both sides of the body and affects the same muscles (bilateral, symmetrical).

  • Children often have a distinctive waddling gait (walking with a sway) and may walk on their toes.

  • Due to muscle weakness, they can develop an anterior pelvic tilt (pelvis tilts forward) and an exaggerated curve in the lower back (lordosis).

• Proximal muscles affected more than distal muscles: The muscles closer to the body's center, especially in the lower limbs, are generally more affected than those in the upper limbs or further from the center.

Dystrophin Structure

• Protein Characteristics:

  • Dystrophin is a very large protein, weighing $427$ kDa (kilodaltons), which makes it difficult to study using certain lab techniques.

  • It has different parts (domains), including an N-terminal and C-terminal end, regions that bind to actin (a protein involved in muscle contraction), and a long rod-like section made of $24$ repeating units with $4$ hinge-like areas. A specific domain that binds to dystroglycan is important for connecting to structures inside the cell.

• Dystrophin Protein Complex: Dystrophin is part of a larger team of proteins called the dystrophin protein complex. This complex acts as a vital link, connecting molecules outside the cell (like proteoglycans such as laminin and collagen) to actin inside the muscle cell. This connection is crucial for maintaining the muscle cell's strength and its ability to properly signal and communicate.

Mutations in Dystrophin Gene

• Types of Mutations: Mistakes in the dystrophin gene are what lead to Duchenne or Becker muscular dystrophy.

  • Duchenne: This usually happens with an 'out-of-frame' mutation, which means the genetic code is misread, leading to the complete absence of a functional dystrophin protein.

  • Becker: This commonly involves an 'in-frame' mutation, where the genetic code is still readable, but it results in a shortened or partially working dystrophin protein.

• Mutation Consequences:

  • The majority of DMD cases are caused by deletions (missing parts of the gene), duplications (extra copies of parts of the gene), or point mutations (changes in a single genetic letter).

  • For example, common deletions often span several exons, frequently between exons $44$ and $53$ of the gene.

Current Treatment Approaches

• No Cure: Currently, there is no cure for DMD. Treatment focuses on palliative care, which means managing symptoms and improving the patient's quality of life. This includes using corticosteroids, medications that can help slow down the disease's progression.

• Physical Therapy: This is very important for keeping muscles flexible and preventing contractures (when muscles and tendons tighten, limiting movement).

• Gene Therapy Approaches: Scientists are researching ways to use gene therapy, which involves using specially modified viruses (recombinant adeno-associated viruses) to deliver correct copies of the dystrophin gene into muscle cells, hoping to repair or replace the faulty dystrophin.

• Antisense Technology: This involves clever techniques like 'exon skipping' and 'stop codon suppression.' Exon skipping aims to trick the cell's machinery into skipping over the mutated part of the gene's instructions (mRNA) to produce a more functional, even if shortened, dystrophin protein. Stop codon suppression targets faulty 'stop' signals in the mRNA that prevent complete protein production, allowing the cell to make a more complete dystrophin.

Physiological Consequences of DMD

• Contraction Types:

  • Isometric: This is when a muscle creates tension to hold something in place but doesn't change its length (e.g., holding a heavy box steady).

  • Isotonic: This is when a muscle shortens as it contracts, causing movement (e.g., lifting a heavy box).

  • Eccentric: This is when a muscle lengthens while still under tension (e.g., slowly lowering a heavy box). In DMD, these lengthening contractions are particularly damaging to the fragile muscle membranes.

• Muscle Regeneration: Special cells called satellite cells are essential for repairing and regenerating muscle after damage. However, in DMD, the muscles are constantly being damaged, and over time, the repair mechanisms can't keep up. This leads to the muscle wasting away (atrophy) and being replaced by scar tissue (fibrosis).

Conclusion

• Muscular dystrophies, especially Duchenne muscular dystrophy, present a big challenge because they are caused by genetic mistakes that lead to severe muscle weakness and eventually the loss of muscle function. Current research is focusing on exciting new drug treatments and gene-based therapies to try and restore dystrophin function and improve the lives of patients.